Adaptive Biotechnologies Corporation (ADPT)
Largest Insider Buys in Sector
ADPT Stock Price History Chart
ADPT Stock Performance
About Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients …
Insider Activity of Adaptive Biotechnologies Corporation
Over the last 12 months, insiders at Adaptive Biotechnologies Corporation have bought $0 and sold $746,782 worth of Adaptive Biotechnologies Corporation stock.
On average, over the past 5 years, insiders at Adaptive Biotechnologies Corporation have bought $0 and sold $111.97M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 250,000 shares for transaction amount of $5M was made by VIKING GLOBAL PERFORMANCE LLC (10 percent owner) on 2019‑07‑01.
List of Insider Buy and Sell Transactions, Adaptive Biotechnologies Corporation
| 2024-11-18 | Sale | Chief Financial Officer | 248 0.0001% | $4.98 | $1,235 | +31.62% | ||
| 2024-08-22 | Sale | SVP and General Counsel | 26,922 0.0138% | $4.50 | $121,079 | +11.93% | ||
| 2024-03-05 | Sale | CEO and Chairman | 48,673 0.0191% | $3.43 | $167,007 | +12.70% | ||
| 2024-03-05 | Sale | Chief Financial Officer | 15,456 0.0061% | $3.44 | $53,169 | +12.70% | ||
| 2024-03-05 | Sale | President | 39,070 0.0155% | $3.47 | $135,764 | +12.70% | ||
| 2024-03-05 | Sale | Chief Commercial Ofc Imm Med | 29,390 0.0115% | $3.44 | $100,994 | +12.70% | ||
| 2024-03-05 | Sale | Chief People Officer | 14,700 0.0058% | $3.43 | $50,439 | +12.70% | ||
| 2024-03-05 | Sale | Chief Commercial Officer, MRD | 12,991 0.0051% | $3.44 | $44,629 | +12.70% | ||
| 2024-03-05 | Sale | SVP and General Counsel | 13,381 0.0052% | $3.43 | $45,963 | +12.70% | ||
| 2024-03-05 | Sale | Principal Accounting Officer | 7,727 0.003% | $3.43 | $26,504 | +12.70% | ||
| 2023-11-16 | Sale | Principal Accounting Officer | 259 0.0001% | $4.13 | $1,070 | +3.47% | ||
| 2023-08-08 | Sale | Chief Commercial Officer, MRD | 10,550 0.0079% | $6.54 | $68,997 | -37.74% | ||
| 2023-08-07 | Sale | Chief Commercial Officer, MRD | 5,652 0.0044% | $6.78 | $38,321 | -38.21% | ||
| 2023-06-20 | Sale | Chief Financial Officer | 134,961 0.1253% | $8.14 | $1.1M | -47.52% | ||
| 2023-06-15 | Sale | Chief Financial Officer | 14,328 0.0139% | $8.53 | $122,218 | -49.60% | ||
| 2023-06-02 | Sale | Chief Financial Officer | 38,000 0.031% | $7.16 | $272,080 | -40.48% | ||
| 2023-04-11 | Sale | Chief Operating Officer | 2,308 0.0023% | $8.63 | $19,918 | -38.31% | ||
| 2023-04-10 | Sale | Chief Operating Officer | 817 0.0008% | $8.50 | $6,945 | -41.15% | ||
| 2023-03-27 | Sale | director | 2,341 0.0023% | $8.49 | $19,878 | -39.51% | ||
| 2023-03-07 | Sale | Chief Commercial Officer, MRD | 9,813 0.0096% | $8.60 | $84,392 | -28.31% |
Insider Historical Profitability
| SPH Group Holdings LLC | 10 percent owner | 41031674 27.8032% | $6.39 | 25 | 0 | |
| STEEL PARTNERS II LP | 10 percent owner | 37094472 25.1353% | $6.39 | 161 | 0 | |
| VIKING GLOBAL PERFORMANCE LLC | 10 percent owner | 30993708 21.0014% | $6.39 | 1 | 2 | <0.0001% |
| Sundaresh Subramanian | President & CEO | 333518 0.226% | $6.39 | 1 | 0 | |
| Dotz Mary | Chief Financial Officer | 0 0% | $6.39 | 1 | 2 |